No profile data available.
Personalis, Inc. (PSNL) is a healthcare company in the laboratory analysis services industry, based in Fremont, United States, with about 259 full-time employees.
It reported revenue of $69.65 million for fiscal year 2025, down 17.7% from fiscal year 2024, and net income of -$81.27 million. United States was its largest region in fiscal year 2025, with 90% of revenue. Its market capitalization was $1.71 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Personalis reported $69.65 million in revenue for fiscal year 2025, down 17.7% from $84.61 million in fiscal year 2024.
United States: 90% of revenue by region in fiscal year 2025, followed by Others (10%).
$1.71 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (laboratory analysis services) include Azenta, Inc. (AZTA), Ginkgo Bioworks Holdings, Inc. (DNA), Dyadic International, Inc. (DYAI).